[Cancer and HIV infection].
Lanoy
Emilie
E
Inserm et Université Pierre et Marie Curie, Université Paris 6 UMR-S-943, Paris Cedex 13, France. elanoy@ccde.chups.jussieu.fr
Guiguet
Marguerite
M
D000328:Adult; D000368:Aged; D019380:Anti-HIV Agents / Q000627:therapeutic use; D015897:Comorbidity; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007157:Immunologic Surveillance; D008231:Lymphopenia / Q000150:complications; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D012306:Risk; D014412:Tumor Virus Infections / Q000276:immunology; D014775:Virus Activation
D019380:Anti-HIV Agents